Thus, ACE inhibitors and angiotensin receptor blockers (ARBs) may reduce the pathogenesis of dementia and cognitive impairment by reducing neuronal inflammation and oxidative stress [100] (Figure 8). Here, ACE is linked to Cognitive impairment.